Viewing Study NCT04520451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-05-08 @ 11:15 PM
Study NCT ID: NCT04520451
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2020-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
Sponsor: Principia Biopharma, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immunoglobulin G4 Related Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None +IgG4 View
None glucocorticoid View
None IgG4-RD View
None BTK View
None Bruton's View